logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jishi Wang

department of hematology
H指数:34
被引数:3,390

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1/CXCR4 axis

更正：在骨髓间充质干细胞中过表达Nrf2通过刺激SDF-1/CXCR4轴促进B细胞急性淋巴细胞白血病细胞的侵袭和外周器官浸润。

Frontiers in Pharmacology
IF4.8
2025-08-080
OA
Lin Zheng; Chengyun Pan; Dan Ma; Qin Shang; Tianzhen Hu; Tianzhuo Zhang; Qian Kang; Xiuying Hu; Shuyun Cao; Li Wang; Hong Luo; Jishi Wang
Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma

新型选择性HDAC I/IIb抑制剂甲磺酸普立诺他在复发/难治性多发性骨髓瘤和淋巴瘤中的临床前期和首次人类

Signal Transduction and Targeted Therapy
IF52.7
2025-06-230
OA
Linyu Yang; Qiang Qiu; Jie Wang; Yi Wen; He Li; Rui Liang; Yunyu Feng; Fang Wang; Xiaojing Lin; Minghai Tang; Jianhong Yang; Heying Pei; Peng Zhao; Jishi Wang; Jin Xiang; Jia Miao; Li Zheng; Ke Tan; Yongsheng Wang; Yiguo Hu; Lijuan Chen; Weili Zhao; Ting Niu
Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial

一种新型10%静脉免疫球蛋白（IVIG）在中国原发性免疫性血小板减少症（ITP）患者中的有效性与安全性：一项多中心、单臂、III期临床试验

CLINICAL AND EXPERIMENTAL MEDICINE
IF3.5
2025-05-120
OA
Cai, Huacong; Wang, Jishi; Yan, Zhenyu; Zhou, Hu; Li, Zhenyu; Yang, Feng'e; Guo, Pengxiang; Gao, Da; Jin, Jie; Zeng, Yun; Wang, Shujie
Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

III期Gecacitinib临床试验结果的事后分析：增强的理解和意义

BLOOD
IF23.1
2024-11-050
PRE
Zhang, Yi; Zhou, Hu; Suo, Shanshan; Zhuang, Junling; Yang, Linhua; He, Aili; Liu, Qingchi; Du, Xin; Gao, Sujun; Li, Yarong; Li, Yan; Chen, Yuqing; Wu, Wen; Zhu, Huanling; He, Guangsheng; Hong, Mei; Jiang, Qian; Jiang, Zhongxing; Jing, Hongmei; Wang, Jishi; Xu, Na; Yue, Lingling; Zheng, Cuiping; Zhou, Zeping; Jin, Chenghao; Li, Xin; Liu, Lin; Xu, Yajing; Wu, Dengshu; Zhang, Feng; Zhang, Jin; Xiao, Zhijian; Jin, Jie
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-10-240
OAAI
Li, Zhiming; Jiang, Wenqi; Zhou, Hui; Cen, Hong; Zhang, Mingzhi; Lv, Fangfang; Zhang, Qingyuan; Sun, Xiuhua; Liu, Lihong; Huang, Yunhong; Yang, Haiyan; Gao, Sujun; He, Chuan; Yang, Wei; Li, Wenyu; Yu, Ding; Yang, Yu; Cheng, Ying; Qian, Zhengzi; Xiang, Ying; Guo, Qunyi; Xu, Bing; Song, Yuqin; Zhang, Liling; Lin, Lie; Shen, Jianzhen; Yan, Feng; Liu, Huilan; Zhang, Donghua; Wang, Jishi; Zhou, Min; Zhu, Xiongpeng; Zhang, Weihua; Zhao, Weili; Feng, Ru; Zhang, Xiaohong; Jin, Jie; Zhong, Meizuo; Zhang, Mei; Wang, Jingbo; Jing, Hongmei; Wang, Zhao; Zhao, Hongguo; Zhu, Jun

研究方向

暂未获取到该数据
Q
Qin Fang
H 指数:27论文数:104被引数:2,126
D
Dan Ma
H 指数:27论文数:139被引数:2,339
C
Chengyun Pan
H 指数:10论文数:56被引数:335
T
Tianzhen Hu
H 指数:8论文数:22被引数:163
L
Lin Lü
H 指数:91论文数:550被引数:3.2万
J
Jianfeng Liu
H 指数:29论文数:85被引数:2,301
T
Tianzhuo Zhang
H 指数:12论文数:56被引数:483
W
Weili Wang
H 指数:10论文数:27被引数:233
Q
Qin Fang
H 指数:17论文数:65被引数:730
薛言学 封面图
薛言学
H 指数:34论文数:104被引数:3,810